How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD? - Wikidata - awgldk - TriplyDB

How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD?

How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD?

http://www.wikidata.org/entity/Q38026402

about

Advances in the medical management of paediatric IBD.Future directions in inflammatory bowel disease management.Optimizing Biologic Agents in Ulcerative Colitis and Crohn's Disease.Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.

P2860

Q38130044-21E2B945-82BB-4F34-8AE1-6C0EBCC9E3F4 Q38205305-38D1E222-7DF4-4350-B2F1-4422277F1CA9 Q38549995-C23D76C5-9F35-4961-A95A-F53E51246BCB Q41329796-07C73FD1-547E-425A-A38F-9F8699E0221F

P2860

How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD?

http://www.wikidata.org/entity/Q38026402

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD?

@en

type

label

How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD?

@en

prefLabel

How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD?

@en

P1433

Q38026402-29621850-7ADE-46DD-97AC-ABAD85849D3E

P1476

Q38026402-9B30140B-6C85-4D8D-8052-EDC3D3B55636

P2860

Q38026402-1B6ADF2E-C419-46B9-A828-2E88DB6C164B

Q38026402-2D6FF228-2B4E-48CF-AAB6-5AC978E9B343

Q38026402-6D5778D6-B3DD-4069-AB41-415D431DAEBE

Q38026402-70399744-216A-4ED3-BD28-422DD5BD641A

Q38026402-A7BC71EF-17E4-415C-A5E8-FE5846F6D622

Q38026402-D6E1F222-D7EA-4EEE-B725-8A038DB54FE4

Q38026402-F30C3D5E-9D02-40DA-A36D-CC94E04E2EF3

P304

Q38026402-1C043E8B-6B72-48E6-8676-E2F7092DB3C9

P31

Q38026402-57A57F7D-83D2-40BA-9275-82E9B771C2BB

P356

Q38026402-7F6328CD-9717-4AC2-A9CE-934B87E9B114

P433

Q38026402-9CB9CD8E-CD77-463D-B19D-BE47BDB14B62

P478

Q38026402-B68ED081-130D-4828-9350-082105148D62

P50

Q38026402-B0D73ACD-157A-42A5-B20B-D95488C46122

P577

Q38026402-3EB17417-780C-4F4C-A589-83675262A547

P698

Q38026402-273580F7-6E00-4648-B457-C6E29783860E

P356

P1433

Digestive Diseases

P1476

How to guide therapeutic decisions in a patient-tailored approach to treatment of IBD?

@en

P2860

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.

Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease.

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.

Long-term evolution of disease behavior of Crohn's disease.

Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease

P304

396-399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000338137

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22796804

http://www.w3.org/2001/XMLSchema#string